-
1 Comment
Tenzing Acquisition Corp is currently in a long term downtrend where the price is trading 25.5% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Tenzing Acquisition Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 354.5% to $-348K since the same quarter in the previous year.
Finally, its free cash flow fell by 253.1% to $-272K since the same quarter in the previous year.
Based on the above factors, Tenzing Acquisition Corp gets an overall score of 1/5.
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| Sector | Financial Services |
| Industry | Shell Companies |
| ISIN | VGG8708A1167 |
| Target Price | None |
|---|---|
| Dividend Yield | 0.0% |
| Beta | 0.01 |
| PE Ratio | None |
| Market Cap | 45M |
As of December 14, 2020, Tenzing Acquisition Corp. was acquired by Reviva Pharmaceuticals, Inc., in a reverse merger transaction. Tenzing Acquisition Corp. does not have significant operations. It intends to acquire, engage in a share exchange, share reconstruction and amalgamation with, purchase all or substantially all of the assets of, enter into contractual arrangements with, or engage in any other similar business combination with one or more businesses or entities primarily operates in India. The company was founded in 2018 and is based in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for TZAC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
